Nanoparticle Synthesis Process Facilitates Chiral Separations

The new building expands on the company’s supply chain solutions for biologics and temperature-sensitive pharmaceuticals.

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

The company’s mocravimod, a novel oral S1P receptor, is being evaluated for its efficacy as an addition to CAR-T cell therapies.

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

The 12th edition of the European Pharmacopoeia will be an all-digital, redesigned, user-friendly issue.

mRNA technologies offer great promise in immunotherapy and non-immunogenic applications.